Skip to main content
. Author manuscript; available in PMC: 2013 Sep 13.
Published in final edited form as: Eur J Neurosci. 2012 Nov 26;37(4):555–563. doi: 10.1111/ejn.12064

Fig. 4.

Fig. 4

In vivo global ischemia results in reduced potentiation of IPSC decay kinetics. (A) Representative recording showing prolongation of the decay kinetics of the IPSC before (control) and after application of etomidate (3 µm). (B) Summary of IPSC decay time constant (ms) in control conditions in sham and CA/CPR. (C) Summary of IPSC decay time constant in the presence of etomidate. Mean ± SEM; *P < 0.05.